Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers.

Zenchenko is among the parents stockpiling Levemir, trying to put off what he fears would be a difficult transition for his son back to the pump or to Lantus.

Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and doctors in a dozen U.S.

A Utah mother is fighting for her teen daughter’s access to diabetes medicine after it was discontinued. Alison Smart, plus other parents and medical experts, discussed the risks and options.

"Lantus peaks [or lowers the blood sugar the most] at six hours after administration, while Levemir peaks at eight to 10 hours after administration.

Novo Nordisk is facing lawmaker pushback on its decision to discontinue its insulin product Levemir, which was due for a steep discount in January.

Three Senate Democrats are demanding answers from Novo Nordisk over its decision to discontinue Levemir, which is FDA-approved for pregnancy.

They also asked Novo Nordisk to explain how patients now on Levemir will get access to "similar long-acting insulin products without gaps in coverage and at similar cost-sharing." Two other, ...

Diabetes patients say they will be harmed by Novo Nordisk's decision to phase out the long-acting insulin Levemir.